Quick answer
United Therapeutics Corporation (UTHR) reported revenue of $3.18B and net income of $1.33B for the fiscal year ended 2025-12-31, up 10.6% from $2.88B the year before, per its 10-K filed with the SEC on 2026-02-25.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $3.18B | $1.33B | — |
| 2024 (FY ending 2024-12-31) | $2.88B | $1.20B | — |
| 2023 (FY ending 2023-12-31) | $2.33B | $984.8M | — |
| 2022 (FY ending 2022-12-31) | $1.94B | $727.3M | — |
| 2021 (FY ending 2021-12-31) | $1.69B | $475.8M | — |
| 2020 (FY ending 2020-12-31) | $1.48B | — | — |
| 2019 (FY ending 2019-12-31) | $1.45B | — | — |
| 2018 (FY ending 2018-12-31) | $1.63B | — | — |
| 2017 (FY ending 2017-12-31) | $1.73B | — | — |
| 2016 (FY ending 2016-12-31) | $1.60B | — | — |
Related
- URI revenue, net income and debt history (United Rentals, Inc.)
- USB revenue, net income and debt history (Us Bancorp \De\)
- USFD revenue, net income and debt history (Us Foods Holding Corp.)
- V revenue, net income and debt history (Visa Inc.)
- VEEV revenue, net income and debt history (Veeva Systems Inc.)
- VIAV revenue, net income and debt history (Viavi Solutions Inc.)
- VICI revenue, net income and debt history (VICI Properties Inc.)
- VICR revenue, net income and debt history (Vicor Corporation)
Last updated 2026-10-16. Data only, not financial or tax advice.